Tempo Scan Pacific Tbk. vs Venteny Fortuna International Tbk. — how do they compare? Tempo Scan Pacific Tbk. trades at Rp2,610 (market cap 11.64T, 278.4K 24h volume), while Venteny Fortuna International Tbk. trades at Rp64 (market cap 432.3B, 23.09M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 26.9× Venteny Fortuna International Tbk.'s market cap, and Venteny Fortuna International Tbk. is more actively traded (23.09M versus 278.4K). Which is the better fit depends on your goals.
| TSPC | VTNY | |
|---|---|---|
Market Cap | 11.64T | 432.3B |
Volume | 278.4K | 23.09M |
Lot | 2.78K | 230.94K |
Turnover | 723.93M | 1.5B |
Average Price | 2,600.31 | 65.14 |
Value | 723.93M | 1.5B |
Indicative Equilibrium Price | 2,610 | 64 |
Indicative Equilibrium Volume | 74 | 1.51K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →PT Venteny Fortuna International Tbk (the Entity) was established based on Notarial Deed No. 7,dated January 29, 2021 of Anastasia Chandra, S.H., M.Kn., Notary in Tangerang. The Entity started its commercial operations in 2021. PT Venteny Fortuna International Tbk is the parent entity, whereas Junichiro Waide is the ultimate beneficial owner.
Read more on VTNY →